These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 18986390)

  • 1. ADAMTS13 cleavage efficiency is altered by mutagenic and, to a lesser extent, polymorphic sequence changes in the A1 and A2 domains of von Willebrand factor.
    Pruss CM; Notley CR; Hegadorn CA; O'Brien LA; Lillicrap D
    Br J Haematol; 2008 Nov; 143(4):552-8. PubMed ID: 18986390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The co-influence of VWD type 2B/2M mutations in the A1 domain and platelet GPIbα on the rate of cleavage to VWF by ADAMTS13.
    Ma Z; Su J; Zhang J; Ling J; Yin J; Bai X; Ruan C
    Thromb Res; 2015 Nov; 136(5):987-95. PubMed ID: 26345337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombospondin-1 and ADAMTS13 competitively bind to VWF A2 and A3 domains in vitro.
    Wang A; Liu F; Dong N; Ma Z; Zhang J; Su J; Zhao Y; Ruan C
    Thromb Res; 2010 Oct; 126(4):e260-5. PubMed ID: 20705333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of a mouse model to elucidate the phenotypic effects of the von Willebrand factor cleavage mutants, Y1605A/M1606A and R1597W.
    Pruss CM; Golder M; Bryant A; Hegadorn C; Haberichter S; Lillicrap D
    J Thromb Haemost; 2012 May; 10(5):940-50. PubMed ID: 22372972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of von Willebrand factor scissile bond cleavage by a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13 (ADAMTS13).
    Xiang Y; de Groot R; Crawley JT; Lane DA
    Proc Natl Acad Sci U S A; 2011 Jul; 108(28):11602-7. PubMed ID: 21705658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of platelet glycoprotein Ibalpha to von Willebrand factor domain A1 stimulates the cleavage of the adjacent domain A2 by ADAMTS13.
    Nishio K; Anderson PJ; Zheng XL; Sadler JE
    Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10578-83. PubMed ID: 15249683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of mutations in the von Willebrand factor A2 domain on ADAMTS13-dependent proteolysis.
    Hassenpflug WA; Budde U; Obser T; Angerhaus D; Drewke E; Schneppenheim S; Schneppenheim R
    Blood; 2006 Mar; 107(6):2339-45. PubMed ID: 16322474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The p.R1819_C1948delinsS mutation makes von Willebrand factor ADAMTS13-resistant and reduces its collagen-binding capacity.
    Daidone V; Saga G; Barbon G; Pontara E; Cattini MG; Morpurgo M; Zanotti G; Casonato A
    Br J Haematol; 2015 Aug; 170(4):564-73. PubMed ID: 25904363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of vWF73 and VWF114 fragments of von Willebrand factor A2 domain and their utilization in detecting ADAMTS13 activity].
    Zhang JY; Ma ZN; Dong NZ; Hu LP; Su J; Wang ZY; Ruan CG
    Zhonghua Xue Ye Xue Za Zhi; 2011 May; 32(5):337-41. PubMed ID: 21729605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Essential role of the disintegrin-like domain in ADAMTS13 function.
    de Groot R; Bardhan A; Ramroop N; Lane DA; Crawley JT
    Blood; 2009 May; 113(22):5609-16. PubMed ID: 19234142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An enzyme immunoassay of ADAMTS13 distinguishes patients with thrombotic thrombocytopenic purpura from normal individuals and carriers of ADAMTS13 mutations.
    Zhou W; Tsai HM
    Thromb Haemost; 2004 Apr; 91(4):806-11. PubMed ID: 15045144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Increased susceptibility of recombinant type 2A von Willebrand factor mutant A1500E to proteolysis by ADAMTS13].
    Zhang JY; Su J; Ma ZN; Dong NZ; Wang YC; Ruan CG
    Zhonghua Xue Ye Xue Za Zhi; 2012 Mar; 33(3):169-72. PubMed ID: 22781599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Species-dependent variability of ADAMTS13-mediated proteolysis of human recombinant von Willebrand factor.
    Varadi K; Rottensteiner H; Vejda S; Weber A; Muchitsch EM; Turecek PL; Ehrlich HJ; Scheiflinger F; Schwarz HP
    J Thromb Haemost; 2009 Jul; 7(7):1134-42. PubMed ID: 19422458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C2362F mutation gives rise to an ADAMTS13-resistant von Willebrand factor.
    Casonato A; Pontara E; Battiston M; Morpurgo M; Cattini MG; Casarin E; Saga G; Daidone V; De Marco L
    Thromb Haemost; 2013 Jun; 109(6):999-1006. PubMed ID: 23446343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An autoantibody epitope comprising residues R660, Y661, and Y665 in the ADAMTS13 spacer domain identifies a binding site for the A2 domain of VWF.
    Pos W; Crawley JT; Fijnheer R; Voorberg J; Lane DA; Luken BM
    Blood; 2010 Feb; 115(8):1640-9. PubMed ID: 20032502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ADAMTS13 substrate recognition of von Willebrand factor A2 domain.
    Zanardelli S; Crawley JT; Chion CK; Lam JK; Preston RJ; Lane DA
    J Biol Chem; 2006 Jan; 281(3):1555-63. PubMed ID: 16221672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A conformation-sensitive monoclonal antibody against the A2 domain of von Willebrand factor reduces its proteolysis by ADAMTS13.
    Zhang J; Ma Z; Dong N; Liu F; Su J; Zhao Y; Shen F; Wang A; Ruan C
    PLoS One; 2011; 6(7):e22157. PubMed ID: 21779388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterization of four ADAMTS13 mutations responsible for congenital thrombotic thrombocytopenic purpura (Upshaw-Schulman syndrome).
    Hommais A; Rayes J; Houllier A; Obert B; Legendre P; Veyradier A; Girma JP; Ribba AS
    Thromb Haemost; 2007 Sep; 98(3):593-9. PubMed ID: 17849048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous exposure of sites in von Willebrand factor for glycoprotein Ib binding and ADAMTS13 cleavage: studies with ristocetin.
    Chen J; Ling M; Fu X; López JA; Chung DW
    Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2625-30. PubMed ID: 22922961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cluster of mutations in the D3 domain of von Willebrand factor correlates with a distinct subgroup of von Willebrand disease: type 2A/IIE.
    Schneppenheim R; Michiels JJ; Obser T; Oyen F; Pieconka A; Schneppenheim S; Will K; Zieger B; Budde U
    Blood; 2010 Jun; 115(23):4894-901. PubMed ID: 20351307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.